Recruiting Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) NCT04374305 Conditions Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more Locations UCLA Medical Center — Los Angeles, California, United States University of Miami — Miami, Florida, United States Indiana University School of Medicine — Indianopolis, Indiana, United States Johns Hopkins Hospital — Baltimore, Maryland, United States View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2) NCT07713745 Conditions Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +40 more Locations Xuanwu Hospital, Capital Medical University — Beijing, Beijing Municipality, China Beijing Tiantan Hospital, Capital Medical University — Beijing, Beijing Municipality, China Chinese PLA General Hospital — Beijing, Beijing Municipality, China The First Hospital of Jilin University — Changchun, Jilin, China View more locations Show fewer locations Loading locations... View Trial Details
